KJIM :: Korean Journal of Internal Medicine

Long Noncoding RNA NKX2-1-AS1 Accelerates Non-Small Cell Lung Cancer Progression through the miR-589-5p/NME1 Axis

Xiaoying Chen, Ruilai Jiang, Xiaocheng Huang, Ling Chen, Xiaogang Hu, Yanbin Wei

Cell Biochemistry and Biophysics.2024;[Epub] CrossRef

Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer

Andrea Sesma, Julian Pardo, Dolores Isla, Eva M. Gálvez, Marta Gascón-Ruiz, Luis Martínez-Lostao, Alba Moratiel, J. Ramón Paño-Pardo, Elisa Quílez, Irene Torres-Ramón, Alfonso Yubero, María Zapata-García, María Pilar Domingo, Patricia Esteban, Rebeca Sanz

Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer

Gian Marco Leone, Saverio Candido, Alessandro Lavoro, Silvia Vivarelli, Giuseppe Gattuso, Daniela Calina, Massimo Libra, Luca Falzone

Recent Advances in Chemotherapy Combined with Immunotherapy for Non-Small Cell Lung Cancer

Advances in Clinical Medicine.2023; 13(08): 13645. CrossRef

Perioperative immunotherapy in stage IB-III non-small cell lung cancer: a critical review of its rationale and considerations

The Korean Journal of Internal Medicine.2023; 38(6): 787. CrossRef

Nanomedicine-Based Gene Delivery for a Truncated Tumor Suppressor RB94 Promotes Lung Cancer Immunity

Sang-Soo Kim, Caroline Doherty, Manish Moghe, Antonina Rait, Kathleen F. Pirollo, Joe B. Harford, Esther H. Chang

Combination of the EP and Anti-PD-1 Pathway or Anti-CTLA-4 for the Phase III Trial of Small-Cell Lung Cancer: A Meta-Analysis

Abdulhakim A. A. Abunasser, Jinmin Xue, Ehab J. A. Balawi, Yuxi Zhu, Yuan Seng Wu

hsa_circ_0003222 accelerates stemness and progression of non-small cell lung cancer by sponging miR-527

Changhui Li, Jiaqi Zhang, Xiaohua Yang, Cheng Hu, Tianqing Chu, Runbo Zhong, Yinchen Shen, Fang Hu, Feng Pan, Jianlin Xu, Jun Lu, Xiaoxuan Zheng, Hai Zhang, Wei Nie, Baohui Han, Xueyan Zhang

Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome

Vinicius Araujo B. de Lima, Annie Borch, Morten Hansen, Arianna Draghi, Iben Spanggaard, Kristoffer Rohrberg, Sine Reker Hadrup, Ulrik Lassen, Inge Marie Svane

Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer

Julian Taugner, Chukwuka Eze, Lukas Käsmann, Olarn Roengvoraphoj, Kathrin Gennen, Monika Karin, Oleg Petrukhnov, Amanda Tufman, Claus Belka, Farkhad Manapov

TGF-β induced EMT and stemness characteristics are associated with epigenetic regulation in lung cancer

Bit Na Kim, Dong Hyuck Ahn, Nahyeon Kang, Chang Dong Yeo, Young Kyoon Kim, Kyo Young Lee, Tae-Jung Kim, Sug Hyung Lee, Mi Sun Park, Hyeon Woo Yim, Jong Y. Park, Chan Kwon Park, Seung Joon Kim

Biomarkers or factors for predicting the efficacy and adverse effects of immune checkpoint inhibitors in lung cancer: achievements and prospective

Chinese Medical Journal.2020; 133(20): 2466. CrossRef

Hypoxia-induced cancer stemness acquisition is associated with CXCR4 activation by its aberrant promoter demethylation

Nahyeon Kang, Su Yeon Choi, Bit Na Kim, Chang Dong Yeo, Chan Kwon Park, Young Kyoon Kim, Tae-Jung Kim, Seong-Beom Lee, Sug Hyung Lee, Jong Y. Park, Mi Sun Park, Hyeon Woo Yim, Seung Joon Kim

Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy

Jun Ying, Danfei Zhou, Tongjie Gu, Jianda Huang, Haijian Liu